{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:29:22Z","timestamp":1790256562806,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bbadis.2013.10.004","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T07:01:04Z","timestamp":1381561264000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Amino Acids as biomarkers in the SOD1G93A mouse model of ALS"],"prefix":"10.1016","volume":"1842","author":[{"given":"Monica","family":"Bame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Grier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Needleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.A.","family":"Brusilow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2013.10.004_bb0005","first-page":"217","article-title":"El Escorial or Awaji criteria in ALS diagnosis, what should we take?","volume":"123","author":"Dengler","year":"2012","journal-title":"Rom. J. Neurol. Psychiatry"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0010","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/01.wco.0000187248.21103.c5","article-title":"Amyotrophic lateral sclerosis: recent advances and future therapies","volume":"18","author":"Nirmalananthan","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00401-012-1022-4","article-title":"The genetics and neuropathology of amyotrophic lateral sclerosis","volume":"124","author":"Al-Chalabi","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1474-4422(08)70293-X","article-title":"Biomarkers in amyotrophic lateral sclerosis","volume":"8","author":"Turner","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03256320","article-title":"Biomarkers in amyotrophic lateral sclerosis: facts and future horizons","volume":"13","author":"Pradat","year":"2009","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.1987.00520130079022","article-title":"Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis","volume":"44","author":"Nakano","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.pmr.2005.08.013","article-title":"Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications","volume":"16","author":"Abmayr","year":"2005","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0040","first-page":"69","article-title":"Plasma amino acids percentages in amyotrophic lateral sclerosis patients","volume":"25","author":"I\u0142zecka","year":"2003"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410280105","article-title":"Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid","volume":"28","author":"Perry","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0404.1993.tb04186.x","article-title":"Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis","volume":"88","author":"Camu","year":"1993","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0055","first-page":"41","article-title":"Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS","volume":"290","author":"Ghoddoussi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0060","first-page":"147","article-title":"Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion","volume":"29","author":"Brusilow","year":"1991"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0076-6879(85)13030-2","article-title":"Glutamine synthetase from mammalian tissues","volume":"113","author":"Meister","year":"1985","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-022X(80)90004-4","article-title":"A rapid colorimetric assay for carbamyl synthetase I","volume":"3","author":"Pierson","year":"1980","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1073\/pnas.59.1.164","article-title":"Phosphorylation of methionine sulfoximine by glutamine synthetase","volume":"59","author":"Ronzio","year":"1968","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.genm.2012.10.014","article-title":"Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS","volume":"9","author":"Bame","year":"2012","journal-title":"Gend. Med."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0090","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.genm.2010.11.010","article-title":"Effects of gender in amyotrophic lateral sclerosis","volume":"7","author":"McCombe","year":"2010","journal-title":"Gend. Med."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17482960801984358","article-title":"Gender difference in levels of Cu\/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis","volume":"9","author":"Frutiger","year":"2008","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0100","doi-asserted-by":"crossref","first-page":"e9805","DOI":"10.1371\/journal.pone.0009805","article-title":"Loss of ALS2\/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking","volume":"5","author":"Hadano","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0105","series-title":"Understanding the gender-based mechanism of MSO in ALS mice: a metabolic characterization of the SOD1G93A mouse model","author":"Bame","year":"2012"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/17482968.2012.706303","article-title":"Amyotrophic lateral sclerosis: a hormonal condition?","volume":"13","author":"Blasco","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0115","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0361-9230(01)00631-1","article-title":"Chronic inhibition of glutamine synthetase is not associated with impairment of learning and memory in mice","volume":"57","author":"Blin","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/17482968.2011.619197","article-title":"Biochemical alterations associated with ALS","volume":"13","author":"Lawton","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0135","first-page":"219","article-title":"Plasma amino acid levels in patients with amyotrophic lateral sclerosis","volume":"107","author":"Iwasaki","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0140","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/14622416.9.4.383","article-title":"Analysis of the adult human plasma metabolome","volume":"9","author":"Lawton","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0145","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1073\/pnas.1300398110","article-title":"Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy","volume":"110","author":"Serio","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0150","doi-asserted-by":"crossref","first-page":"E756","DOI":"10.1073\/pnas.1222361110","article-title":"Intricate interplay between astrocytes and motor neurons in ALS","volume":"110","author":"Phatnani","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ymgme.2011.11.201","article-title":"ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations","volume":"105","author":"Wuolikainen","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0160","first-page":"349","article-title":"Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis","volume":"6","author":"Chiu","year":"1995","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0165","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0170","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0175","doi-asserted-by":"crossref","first-page":"e22374","DOI":"10.1371\/journal.pone.0022374","article-title":"Abnormal changes in NKT cells, the IGF-1 axis, and liver pathology in an animal model of ALS","volume":"6","author":"Finkelstein","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0180","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.1308421110","article-title":"Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis","volume":"108","author":"Dodge","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0185","first-page":"1","article-title":"The \u2018golden age\u2019 of DNA methylation in neurodegenerative diseases","author":"Fuso","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13670-012-0026-1","article-title":"DNA methylation in neurodegenerative disorders","volume":"1","author":"Xu","year":"2012","journal-title":"Curr. Transl. Geriatr. Gerontol. Rep."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13670-012-0027-0","article-title":"Epigenetics-based therapeutics for neurodegenerative disorders","volume":"1","author":"Xu","year":"2012","journal-title":"Curr. Transl. Geriatr. Gerontol. Rep."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/17482960802635397","article-title":"A genome-wide analysis of brain DNA methylation identifies new candidate genes for sporadic amyotrophic lateral sclerosis","volume":"10","author":"Morahan","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0205","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.biochi.2011.09.013","article-title":"Extracellular cysteine (Cys)\/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity","volume":"94","author":"Zhu","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/srep00266","article-title":"Activated human CD4 T cells express transporters for both cysteine and cystine","volume":"2","author":"Levring","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0215","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/pr.110.003889","article-title":"Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling","volume":"64","author":"Bridges","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0220","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1054-3589(08)61000-5","article-title":"Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine","volume":"38","author":"Dr\u00f6ge","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1096\/fasebj.11.1.9034170","article-title":"Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV\/SIV infection, and senescence","volume":"11","author":"Hack","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0230","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2011.04.025","article-title":"Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1G93A mice model","volume":"43","author":"Vargas","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0235","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2011.04.003","article-title":"Glutamate and glutathione interplay in a motor neuronal model of amyotrophic lateral sclerosis reveals altered energy metabolism","volume":"43","author":"D'Alessandro","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0240","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1523\/JNEUROSCI.1639-11.2011","article-title":"Epigenetic regulation of motor neuron cell death through DNA methylation","volume":"31","author":"Chestnut","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0245","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0250","first-page":"222","article-title":"Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis","volume":"70","author":"Zoccolella","year":"2008"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/85.1.19","article-title":"Methyl balance and transmethylation fluxes in humans","volume":"85","author":"Mudd","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0260","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1734-1140(10)70279-6","article-title":"Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure models","volume":"62","author":"Soca\u0142a","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0265","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1517\/17425255.2010.522177","article-title":"The biochemical and toxicological significance of hypermethionemia: new insights and clinical relevance","volume":"6","author":"Dever","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.nutr.28.061807.155438","article-title":"Methionine metabolism and liver disease","volume":"28","author":"Mato","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ana.410030405","article-title":"Free amino acid levels in amyotrophic lateral sclerosis","volume":"3","author":"Patten","year":"1978","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0280","first-page":"348","article-title":"Plasma amino acids in ecstasy users","volume":"24","author":"Stuerenburg","year":"2003"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03161056","article-title":"Possible roles of l-phosphoserine in the pathogenesis of Alzheimer's disease","volume":"15","author":"Klunk","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0290","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/cbdv.200900306","article-title":"Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate\/D-serine vs. inhibitory glycine\/gamma-aminobutanoic acid (GABA)","volume":"7","author":"Sasabe","year":"2010","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0295","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/sj.emboj.7601840","article-title":"D-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis","volume":"26","author":"Sasabe","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0300","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1073\/pnas.0702230104","article-title":"Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons","volume":"104","author":"Lobsiger","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0305","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-8993(87)90471-9","article-title":"Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease","volume":"417","author":"Ellison","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/msb.2008.34","article-title":"Gender-dependent progression of systemic metabolic states in early childhood","volume":"4","author":"Nikkil\u00e4","year":"2008","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0315","doi-asserted-by":"crossref","first-page":"e1002215","DOI":"10.1371\/journal.pgen.1002215","article-title":"Discovery of sexual dimorphisms in metabolic and genetic biomarkers","volume":"7","author":"Mittelstrass","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0320","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2013.10.004_bb0325","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1471-4159.1969.tb05937.x","article-title":"Glycogen, ammonia and related metabolities in the brain during seizures evoked by methionine sulphoximine","volume":"16","author":"Folbergrov\u00e1","year":"1969","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0330","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0197-0186(99)00141-2","article-title":"Acidosis and astrocyte amino acid metabolism","volume":"36","author":"Yudkoff","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0335","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0261-5614(03)00041-4","article-title":"Effect of acute acidosis on protein and amino acid metabolism in rats","volume":"22","author":"\u0160afr\u00e1nek","year":"2003","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0340","first-page":"465","article-title":"Cerebral methylations in epileptogenesis","volume":"44","author":"Sellinger","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1471-4159.1975.tb07628.x","article-title":"Effect of methionine and methionine sulphoximine on rat brain S-adenosyl methionine levels","volume":"24","author":"Schatz","year":"1975","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2013.10.004_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1471-4159.1975.tb07696.x","article-title":"The elevation of cerebral histamine-N-and catechol-O-methyl transferase activities by L-methionine-dl-sulfoximine","volume":"25","author":"Schatz","year":"1975","journal-title":"J. Neurochem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913002986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443913002986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T19:13:19Z","timestamp":1564513999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443913002986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0925443913002986"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.004","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino Acids as biomarkers in the SOD1G93A mouse model of ALS","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2013.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}